Up-regulated claudin 7 expression in intestinal-type gastric carcinoma
- PMID: 17611659
Up-regulated claudin 7 expression in intestinal-type gastric carcinoma
Abstract
The disruption of tight junction protein expression in cancer might account for invasiveness, loss of cohesion, and lack of differentiation. Our cDNA array data indicated that claudin 7 was up-regulated in gastric carcinoma. We investigated the expression patterns and clinical implications of claudin 7 in gastric cancer. By immunohistochemical staining and Western blot, claudin 7 was significantly more often expressed in intestinal metaplasia, adenoma and cancer than in normal gastric epithelium. Twenty-seven (47.4%) of 57 normal gastric epithelium samples did not express claudin 7, but 50 (86.2%) of 58 intestinal metaplasia, 11 (91.7%) of 12 adenoma tissues, and 129 (82.7%) of 156 cancer samples did. Claudin 7 was more often unexpressed in diffuse type gastric cancer than in intestinal type. Only 13 (11.2%) of 116 intestinal type samples did not express claudin 7, but 14 (41.2%) of 34 diffuse type samples showed no expression. Compared to normal gastric epithelium, intestinal type gastric cancer significantly more often expressed claudin 7, but diffuse type did not. The expression pattern of claudin 7 did not change as cancer progressed. In this study we show that claudin 7 expression changed with the gastric carcinogenic process and that this is implicated in cancer characteristics.
Similar articles
-
The role of Reg IV gene and its encoding product in gastric carcinogenesis.Hum Pathol. 2010 Jan;41(1):59-69. doi: 10.1016/j.humpath.2009.06.013. Epub 2009 Sep 8. Hum Pathol. 2010. PMID: 19740514
-
Down-regulation of the claudin-18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype.J Pathol. 2006 Apr;208(5):633-42. doi: 10.1002/path.1922. J Pathol. 2006. PMID: 16435283
-
Loss of the tight junction protein claudin 4 correlates with histological growth-pattern and differentiation in advanced gastric adenocarcinoma.Oncol Rep. 2005 Feb;13(2):193-9. Oncol Rep. 2005. PMID: 15643498
-
Pathology and molecular biology of gastric cancer.Best Pract Res Clin Gastroenterol. 2006;20(4):651-74. doi: 10.1016/j.bpg.2006.03.016. Best Pract Res Clin Gastroenterol. 2006. PMID: 16997151 Review.
-
Pathological studies of human gastric cancer.Acta Pathol Jpn. 1982;32 Suppl 2:329-47. Acta Pathol Jpn. 1982. PMID: 6765003 Review.
Cited by
-
Claudin-7 Inhibits Proliferation and Metastasis in Salivary Adenoid Cystic Carcinoma Through Wnt/β-Catenin Signaling.Cell Transplant. 2020 Jan-Dec;29:963689720943583. doi: 10.1177/0963689720943583. Cell Transplant. 2020. PMID: 32749148 Free PMC article.
-
Claudin 18.2 as a novel therapeutic target.Nat Rev Clin Oncol. 2024 May;21(5):354-369. doi: 10.1038/s41571-024-00874-2. Epub 2024 Mar 19. Nat Rev Clin Oncol. 2024. PMID: 38503878 Review.
-
Tannic Acid and Ethacridine Lactate Attenuate Markers of Stress-Induced Intestinal Barrier Dysfunctions in Murine Small Intestinal Organoids.Biomolecules. 2025 Apr 30;15(5):650. doi: 10.3390/biom15050650. Biomolecules. 2025. PMID: 40427543 Free PMC article.
-
Acute oxidative stress affects IL-8 and TNF-α expression in IPEC-J2 porcine epithelial cells.Inflammation. 2012 Jun;35(3):994-1004. doi: 10.1007/s10753-011-9403-8. Inflammation. 2012. PMID: 22083491
-
Emerging clinical significance of claudin-7 in colorectal cancer: a review.Cancer Manag Res. 2018 Sep 20;10:3741-3752. doi: 10.2147/CMAR.S175383. eCollection 2018. Cancer Manag Res. 2018. PMID: 30288105 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical